About Evoke Pharma (EVOK)

Evoke Pharma Inc (EVOK) is a pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastrointestinal disorders. The company's main product is Gimoti, a nasal spray formulation of metoclopramide for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in adults. This condition is characterized by delayed gastric emptying and can cause symptoms such as nausea, vomiting, and feeling full quickly. Gimoti is designed to bypass the gastrointestinal tract and deliver the medication directly to the bloodstream, providing rapid and consistent relief to patients.

The stock price history of Evoke Pharma Inc (EVOK) has seen both ups and downs over the years. The company went public in 2013, and since then, the stock has experienced fluctuations in response to various factors such as clinical trial results, regulatory approvals, and market conditions. It is important for investors to carefully analyze the stock's performance and conduct thorough research before making any investment decisions.